Study Title: A Phase 3 Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared with Investigators Choice Monotherapy Treatment in Previously Treated Patients with Incurable, Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, John Kaczmar, at kaczmar@musc.edu, or please call +1 843-792-6691.Study Coordinator, Madison Avinger, at avingerm@musc.edu.Trial opened at the following institutions: Medical University of South Carolina